Drugs in Dev.
Sleep
Phase II
Sweden 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Golexanolone
Therapeutic Area : Sleep
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Analyses of data for additional efficacy endpoints reveal that treatment with the golexanolone exerts a significant effect on brain signaling with a positive effect on excessive daytime sleepiness.
Product Name : Undisclosed
Product Type : Steroid
Upfront Cash : Inapplicable
May 08, 2020
Lead Product(s) : Golexanolone
Therapeutic Area : Sleep
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
